Eur J Pediatr Surg 1999; 9: 12-14
DOI: 10.1055/s-2008-1072304
Original article

© Georg Thieme Verlag KG Stuttgart · New York

19-Year Follow-Up of Fetal Myelomeningocele Brought to Term

S. L. Liu1 , D. B. Shurtleff1 , R. G. Ellenbogen2 , J. D. Loeser2 , R.  Kropp
  • 1Department of Pediatrics, CH-47, University of Washington, Seattle, Washington 98195
  • 2Department of Neurological Surgery, University of Washington, Seattle, Washington 98195, USA
Further Information

Publication History

Publication Date:
25 March 2008 (online)

Abstract

We conducted a 19-year follow-up study of 223 infants with myelomeningocele born by cephalic presentation, 68 born by pre-rupture of amniotic membranes cesarean section (PRAM C/S) and 155 born vaginally to determine outcome. We recorded radiographic level as the last intact vertebral arch at the cephalad end of the spinal defect from standard AP films of the spine. Protrusions of the lesions dorsal to the back were obtained from medical records or parental recall. Subsequent spinal cord abnormalities (hydromyelia, tethered cord and hypoplasia) were determined by patient's symptoms and verified by MRI. Data were from our Patient Data Management System and analyzed using Microsoft Excel and Epi Info 6. Flat lesions protruding less than 1.0 cm beyond the plane of the back and those associated with breech position or kyphus were not benefited by PRAM C/S (Fisher's Exact, p = 0.58 between the two types of delivery for motor level). Flat lesions were more common in the vaginally delivered group (p = 0.01). Lesions protruding equal to 1.0 cm or beyond were associated with less paralysis after PRAM C/S (p = 0.01). Although tethered cord syndrome was more common in the PRAM C/S group (p = 0.02), there was no difference in the muscle strength loss between the PRAM C/S and the vaginally delivered groups. Symptomatic hydromyelia was equally distributed but spinal cord hypoplasia was more common in the PRAM C/S group (p = 0.03). Due to the limited numbers of patients in each group available for analysis, we recommend further study to ascertain the appropriate management of fetal myelomeningocele diagnosed in utero and brought to term.

    >